Age-related disruption of the proteome and acetylome in mouse hearts is associated with loss of function and attenuated by elamipretide (SS-31) and nicotinamide mononucleotide (NMN) treatment

Geroscience. 2022 Jun;44(3):1621-1639. doi: 10.1007/s11357-022-00564-w. Epub 2022 Apr 13.

Abstract

We analyzed the effects of aging on protein abundance and acetylation, as well as the ability of the mitochondrial-targeted drugs elamipretide (SS-31) and nicotinamide mononucleotide (NMN) to reverse aging-associated changes in mouse hearts. Both drugs had a modest effect on restoring the abundance and acetylation of proteins that are altered with age, while also inducing additional changes. Age-related increases in protein acetylation were predominantly in mitochondrial pathways such as mitochondrial dysfunction, oxidative phosphorylation, and TCA cycle signaling. We further assessed how these age-related changes associated with diastolic function (Ea/Aa) and systolic function (fractional shortening under higher workload) measurements from echocardiography. These results identify a subset of protein abundance and acetylation changes in muscle, mitochondrial, and structural proteins that appear to be essential in regulating diastolic function in old hearts.

Keywords: Acetylomics; Aging; Elamipretide; Heart; Mitochondria; NMN; Proteomics; SS-31.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Mice
  • Mitochondria / metabolism
  • Nicotinamide Mononucleotide* / pharmacology
  • Oligopeptides / metabolism
  • Oligopeptides / pharmacology
  • Proteome* / metabolism
  • Proteome* / pharmacology

Substances

  • Oligopeptides
  • Proteome
  • arginyl-2,'6'-dimethyltyrosyl-lysyl-phenylalaninamide
  • Nicotinamide Mononucleotide